| CAPITAL GROUP JAPAN EQUITY FUND (LUX) BH EUR | RVI JAPÓN | 31,49% | 78,69% | 90,65% | 230,68% |
| L&G JAPAN EQUITY UCITS ETF USD ACC ETF | RVI JAPÓN | 31,49% | 67,71% | · | · |
| BGF ASIAN DRAGON A4 GBP | RVI ASIA EX-JAPÓN | 31,48% | 62,94% | 41,15% | 107,59% |
| EURIZON FUND-SUSTAINABLE JAPAN EQUITY Z EUR | RVI JAPÓN | 31,48% | 65,95% | 75,09% | · |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 31,48% | 91,28% | 49,02% | 96,23% |
| T.ROWE JAPANESE EQUITY FUND C | RVI JAPÓN | 31,48% | 65,23% | 17,91% | · |
| AMUNDI JAPAN TOPIX UCITS ETF JPY CAP | RVI JAPÓN | 31,47% | 66,72% | 65,93% | · |
| SCHRODER ISF ASIAN EQUITY YIELD A ACC CHF | RVI ASIA EX-JAPÓN VALOR | 31,47% | 76,19% | 70,54% | 133,90% |
| ISHARES JAPAN INDEX FUND (IE) FLEXIBLE EUR DIS | RVI JAPÓN | 31,46% | 60,05% | 52,07% | · |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND I USD HEDGED | RVI JAPÓN VALOR | 31,46% | 94,64% | 209,35% | 402,71% |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 31,45% | 37,36% | -19,85% | · |
| AMUNDI CORE MSCI EMERGING MARKETS UCITS ETF DR DIS | RVI EMERGENTES | 31,44% | 67,89% | 40,30% | · |
| GVC GAESCO CROSSOVER / GEOPOLITICAL HEDGING RVMI A | MIXTO AGRESIVO GLOBAL | 31,44% | 101,61% | · | · |
| ISHARES MSCI EM UCITS ETF USD (DIST) | RVI EMERGENTES | 31,44% | 69,98% | 41,84% | 88,90% |
| PICTET - BIOTECH HP EUR | RVI BIOTECNOLOGÍA | 31,44% | 80,52% | 34,02% | 87,40% |
| BGF ASIAN DRAGON A2 EUR | RVI ASIA EX-JAPÓN | 31,43% | 64,15% | 42,58% | 110,96% |
| T.ROWE JAPANESE EQUITY FUND I (USD) | RVI JAPÓN | 31,43% | 65,08% | 17,50% | · |
| UBS CORE MSCI EM UCITS ETF USD DIS | RVI EMERGENTES | 31,43% | 68,66% | 41,52% | 88,28% |
| AMUNDI CORE MSCI EMERGING MARKETS IE DIS | RVI EMERGENTES | 31,42% | 67,79% | 40,18% | · |
| AMUNDI FUNDS EMERGING WORLD EQUITY I USD (C) | RVI EMERGENTES | 31,42% | 72,00% | 52,54% | 127,14% |
